No Evidence for WT1 Involvement in a Beta-Catenin-Independent Activation of the Wnt Signaling Pathway in Pituitary Adenomas

[1]  M. Weller,et al.  Diagnostic value of WT1 in neuroepithelial tumours , 2009, Neuropathology and applied neurobiology.

[2]  S. Takekoshi,et al.  Expression of Wnt4 in Human Pituitary Adenomas Regulates Activation of the β-Catenin-Independent Pathway , 2008, Endocrine pathology.

[3]  Chengquan Zhao,et al.  SF-1 is a Diagnostically Useful Immunohistochemical Marker and Comparable to Other Sex Cord-Stromal Tumor Markers for the Differential Diagnosis of Ovarian Sertoli Cell Tumor , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[4]  K. Tomizuka,et al.  R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. , 2008, Human molecular genetics.

[5]  Martin Reincke,et al.  Growth modelling of non-functioning pituitary adenomas in patients referred for surgery. , 2008, European journal of endocrinology.

[6]  G. Kourounis,et al.  Fallopian tube malignant mixed müllerian tumor (carcinosarcoma): a case report with immunohistochemical profiling. , 2008, European journal of gynaecological oncology.

[7]  Cun-Yu Wang,et al.  Noncanonical Wnt-4 Signaling Enhances Bone Regeneration of Mesenchymal Stem Cells in Craniofacial Defects through Activation of p38 MAPK* , 2007, Journal of Biological Chemistry.

[8]  M. Minden,et al.  A tumor suppressor and oncogene: the WT1 story , 2007, Leukemia.

[9]  G. Fraizer,et al.  Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. , 2007, Frontiers in bioscience : a journal and virtual library.

[10]  I. Kawase,et al.  Immunohistochemical detection of WT1 protein in a variety of cancer cells , 2006, Modern Pathology.

[11]  B. Williams,et al.  Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells. , 2006, Gene expression.

[12]  J. Mulliken,et al.  Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. , 2005, Archives of dermatology.

[13]  E. Raso,et al.  WT1 expression in angiogenic tumours of the skin , 2005, Histopathology.

[14]  Toshiki Yoshimine,et al.  Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors , 2004, Cancer science.

[15]  R. DeLellis.  Pathology and genetics of tumours of endocrine organs , 2004 .

[16]  H. Yoshikawa,et al.  Overexpression of the Wilms' tumor gene WT1 in human bone and soft‐tissue sarcomas , 2003, Cancer science.

[17]  M. Little,et al.  Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1 , 2002, Oncogene.

[18]  B. Scheithauer,et al.  Metastases to the pituitary gland , 2002 .

[19]  C. B. Patel,et al.  Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. , 2001, Cancer research.

[20]  E. Bertelmann,et al.  Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens , 2000, Journal of Cancer Research and Clinical Oncology.

[21]  S. Melmed,et al.  New pituitary oncogenes. , 2000, Endocrine-related cancer.

[22]  S. Asa,et al.  The cytogenesis and pathogenesis of pituitary adenomas. , 1998, Endocrine reviews.

[23]  E. van Marck,et al.  WT1 MUTATION IN MALIGNANT MESOTHELIOMA AND WT1 IMMUNOREACTIVITY IN RELATION TO p53 AND GROWTH FACTOR RECEPTOR EXPRESSION, CELL‐TYPE TRANSITION, AND PROGNOSIS , 1997, The Journal of pathology.

[24]  W. Saeger,et al.  [Prolactin producing hypophyseal carcinoma. Case report of an extremely rare metastatic tumor]. , 1995, Der Pathologe.

[25]  W. Saeger,et al.  Prolaktinbildendes Hypophysenkarzinom Kasuistik eines äußerst seltenen metastasierenden Tumors* , 1995, Der Pathologe.

[26]  Z. Wang,et al.  Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. , 1995, Oncogene.

[27]  E. Thiel,et al.  Expression of the WT1 Wilms' tumor gene by normal and malignant human melanocytes , 1994, International journal of cancer.

[28]  N. Hastie,et al.  The genetics of Wilms' tumor--a case of disrupted development. , 1994, Annual review of genetics.

[29]  Amy Bernard,et al.  Physical and functional interaction between WT1 and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Housman,et al.  Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development , 1991, Molecular and cellular biology.

[31]  W. Saeger,et al.  [Metastases in the hypophysis and sella]. , 1985, Der Pathologe.